<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37342987</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-6535</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical pharmacology and therapeutics</Title><ISOAbbreviation>Clin Pharmacol Ther</ISOAbbreviation></Journal><ArticleTitle>Prognostic Factors of COVID-19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology.</ArticleTitle><Pagination><StartPage>604</StartPage><EndPage>613</EndPage><MedlinePgn>604-613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cpt.2977</ELocationID><Abstract><AbstractText>During the coronavirus disease 2019 (COVID-19) pandemic, the urgency for updated evidence to inform public health and clinical care placed systematic literature reviews (SLRs) at the cornerstone of research. We aimed to summarize evidence on prognostic factors for COVID-19 outcomes through published SLRs and to critically assess quality elements in the findings' interpretation. An umbrella review was conducted via electronic databases from January 2020 to April 2022. All SLRs (and meta-analyses) in English were considered. Data screening and extraction were conducted by two independent reviewers. AMSTAR 2 tool was used to assess SLR quality. The study was registered with PROSPERO (CRD4202232576). Out of 4,564 publications, 171 SLRs were included of which 3 were umbrella reviews. Our primary analysis included 35 SLRs published in 2022, which incorporated studies since the beginning of the pandemic. Consistent findings showed that, for adults, older age, obesity, heart disease, diabetes, and cancer were more strongly predictive of risk of hospitalization, intensive care unit admission, and mortality due to COVID-19. Male sex was associated with higher risk of short-term adverse outcomes, but female sex was associated with higher risk of long COVID. For children, socioeconomic determinants that may unravel COVID-19 disparities were rarely reported. This review highlights key prognostic factors of COVID-19, which can help clinicians and health officers identify high-risk groups for optimal care. Findings can also help optimize confounding adjustment and patient phenotyping in comparative effectiveness research. A living SLR approach may facilitate dissemination of new findings. This paper is endorsed by the International Society for Pharmacoepidemiology.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Clinical Pharmacology &amp; Therapeutics &#xa9; 2023 American Society for Clinical Pharmacology and Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sarri</LastName><ForeName>Grammati</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5536-8038</Identifier><AffiliationInfo><Affiliation>Cytel, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-0434-4674</Identifier><AffiliationInfo><Affiliation>Office of Surveillance and Epidemiology, CDER, US Food and Drug Administration, Silver Spring, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabotka</LastName><ForeName>Luke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freitag</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0265-9338</Identifier><AffiliationInfo><Affiliation>Cytel, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claire</LastName><ForeName>Ravinder</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8039-6161</Identifier><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wangge</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Monash University, Banten, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elvidge</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawoud</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2105-1937</Identifier><AffiliationInfo><Affiliation>National Institute for Health and Care Excellence, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Dimitri</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8387-9342</Identifier><AffiliationInfo><Affiliation>Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Xuerong</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-4803-7895</Identifier><AffiliationInfo><Affiliation>College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaojuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rentsch</LastName><ForeName>Christopher T</ForeName><Initials>CT</Initials><Identifier Source="ORCID">0000-0002-1408-7907</Identifier><AffiliationInfo><Affiliation>Faculty of Epidemiology and Population Health, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uddin</LastName><ForeName>Md Jamal</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Statistics, Shahjalal University of Science and Technology, Sylhet, Bangladesh.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Educational Development (GED), Daffodil International University, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>M Sanni</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Faculty of Public Health and Policy, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gokhale</LastName><ForeName>Mugdha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pfizer Inc., New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xe9;ruaz-Luyet</LastName><ForeName>Anouk</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7396-7392</Identifier><AffiliationInfo><Affiliation>Boehringer Ingelheim International GmbH, Ingelheim-am-Rhein, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moga</LastName><ForeName>Daniela C</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0002-3648-8197</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jeff Jianfei</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Pharmacy Practice &amp; Administrative Sciences, College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zullo</LastName><ForeName>Andrew R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0003-1673-4570</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patorno</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Kueiyu Joshua</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 AG073651</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG065722</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG077620</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG061632</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Pharmacol Ther</MedlineTA><NlmUniqueID>0372741</NlmUniqueID><ISSNLinking>0009-9236</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017891" MajorTopicYN="N">Pharmacoepidemiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37342987</ArticleId><ArticleId IdType="doi">10.1002/cpt.2977</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The COVID decade: understanding the long-term societal impacts of COVID-19. The British Academy &lt;https://www.thebritishacademy.ac.uk/publications/covid-decade-understanding-the-long-term-societal-impacts-of-covid-19/&gt;. Accessed January 5, 2023.</Citation></Reference><Reference><Citation>Osterrieder, A. et al. Economic and social impacts of COVID-19 and public health measures: results from an anonymous online survey in Thailand, Malaysia, the UK, Italy and Slovenia. BMJ Open 11, e046863 (2021).</Citation></Reference><Reference><Citation>Sharma, J., Rajput, R., Bhatia, M., Arora, P. &amp; Sood, V. Clinical predictors of COVID-19 severity and mortality: a perspective. Front. Cell. Infect. Microbiol. 25, 674277 (2021).</Citation></Reference><Reference><Citation>Gough, D. et al. Evidence Synthesis International (ESI): position statement. Syst. Rev. 9, 155 (2020).</Citation></Reference><Reference><Citation>Elliott, J. et al. Decision makers need constantly updated evidence synthesis. Nature 600, 383-385 (2021).</Citation></Reference><Reference><Citation>Wynants, L. et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 7, m1328 (2020).</Citation></Reference><Reference><Citation>Living guidance for clinical management of COVID-19 &lt;https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-clinical-2021-2&gt;. Accessed January 6, 2023.</Citation></Reference><Reference><Citation>Sarri, G. et al. ISPE-endorsed guidance in using electronic health records for comparative effectiveness research in COVID-19: opportunities and trade-offs. Clin. Pharmacol. Ther. 112, 990-999 (2022).</Citation></Reference><Reference><Citation>Page, M.J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).</Citation></Reference><Reference><Citation>Post COVID-19 condition (Long COVID) &lt;https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition&gt;. Accessed January 6, 2023.</Citation></Reference><Reference><Citation>Shea, B.J. et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 21, j4008 (2017).</Citation></Reference><Reference><Citation>Romero Starke, K., Reissig, D., Petereit-Haack, G., Schmauder, S., Nienhaus, A. &amp; Seidler, A. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Glob. Health 6, e006434 (2021).</Citation></Reference><Reference><Citation>Harrison, S.L., Buckley, B.J.R., Rivera-Caravaca, J.M., Zhang, J. &amp; Lip, G.Y.H. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur. Heart J. Qual. Care Clin. Outcomes 7, 330-339 (2021).</Citation></Reference><Reference><Citation>Asiimwe, I.G., Pushpakom, S., Turner, R.M., Kolamunnage-Dona, R., Jorgensen, A.L. &amp; Pirmohamed, M. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br. J. Clin. Pharmacol. 87, 4534-4545 (2021).</Citation></Reference><Reference><Citation>Dumitrascu, F., Branje, K.E., Hladkowicz, E.S., Lalu, M. &amp; McIsaac, D.I. Association of frailty with outcomes in individuals with COVID-19: a living review and meta-analysis. J. Am. Geriatr. Soc. 69, 2419-2429 (2021).</Citation></Reference><Reference><Citation>Simons, D., Shahab, L., Brown, J. &amp; Perski, O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addict. Abingdon Engl. 116, 1319-1368 (2021).</Citation></Reference><Reference><Citation>Akbari, A. et al. Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: a systematic review and meta-analysis. Am. J. Emerg. Med. 52, 166-173 (2022).</Citation></Reference><Reference><Citation>Alzoughool, F., Abumweis, S., Alanagreh, L. &amp; Atoum, M. Associations of pre-existing cardiovascular morbidity with severity and the fatality rate in COVID-19 patients: a systematic review and meta-analysis. Osong. Public Health Res. Perspect. 13, 37-50 (2022).</Citation></Reference><Reference><Citation>Baker, J., Krishnan, N., Abroms, L.C. &amp; Berg, C.J. The impact of tobacco use on COVID-19 outcomes: a systematic review. J. Smok. Cessat. 2022, 5474397 (2022).</Citation></Reference><Reference><Citation>Bellou, V., Tzoulaki, I., van Smeden, M., Moons, K.G.M., Evangelou, E. &amp; Belbasis, L. Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis. Eur. Respir. J. 59, 2002964 (2022).</Citation></Reference><Reference><Citation>Boden, I. et al. Pre-existing diabetic retinopathy as a prognostic factor for COVID-19 outcomes amongst people with diabetes: a systematic review. Diabetes Res. Clin. Pract. 187, 109869 (2022).</Citation></Reference><Reference><Citation>&#xc7;&#x131;nar, F. &amp; Ekinci, G. Investigation of the effect of comorbidity on mortality in patients with covid-19: a systematic review and meta-analysis. Biointerface Res. Appl. Chem. 12, 5579-5590 (2022).</Citation></Reference><Reference><Citation>Darvishzadeh, A., Hasani, H., Behrouzinezhad, R., Bahmani, A. &amp; Delavar, M. Evaluation of predictors of mortality in patients with COVID-19: a systematic review and meta-analysis. Eurasian Chem. Commun. 4, 392-401 (2022).</Citation></Reference><Reference><Citation>Dissanayake, H.A. et al. Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 107, 1484-1502 (2022).</Citation></Reference><Reference><Citation>El-Qushayri, A.E., Ghozy, S., Reda, A., Kamel, A.M.A., Abbas, A.S. &amp; Dmytriw, A.A. The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: a systematic review and meta-analysis. Rev. Med. Virol. 32, e2278 (2022).</Citation></Reference><Reference><Citation>Fabi&#xe3;o, J. et al. Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age. Braz. J. Med. Biol. Res. Rev. Bras. Pesqui. Medicas E Biol. 55, e11711 (2022).</Citation></Reference><Reference><Citation>Halim, C., Mirza, A.F. &amp; Sari, M.I. The association between TNF-&#x3b1;, IL-6, and vitamin D levels and COVID-19 severity and mortality: a systematic review and meta-analysis. Pathogens 11, 195 (2022).</Citation></Reference><Reference><Citation>Han et al. Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis. BMJ Open, e044661 (2022). doi: 10.1136/bmjopen-2020-044661.</Citation></Reference><Reference><Citation>Hu, Y., Kung, J., Cave, A. &amp; Banh, H.L. Effects of vitamin D serum level on morbidity and mortality in patients with COVID-19: a systematic review and meta-analysis. J. Pharm. Pharm. Sci. Publ. Can. Soc. Pharm. Sci. Soc. Can. Sci. Pharm. 25, 84-92 (2022).</Citation></Reference><Reference><Citation>Banerjee, A. et al. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur. J. Prev. Cardiol. 28, 1599-1609 (2021).</Citation></Reference><Reference><Citation>Maglietta, G. et al. Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J. Clin. Med. 11, 1541 (2022).</Citation></Reference><Reference><Citation>Jordan, T., Siuka, D., Rotovnik, N.K. &amp; Pfeifer, M. COVID-19 and vitamin D - a systematic review. Zdr. Varst. 61, 124-132 (2022).</Citation></Reference><Reference><Citation>Li, S. et al. The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates. Neurol. Sci. 43, 4049-4059 (2022).</Citation></Reference><Reference><Citation>Ming, W., Zuo, J., Han, J. &amp; Chen, J. The impact of comorbid allergic airway disease on the severity and mortality of COVID-19: a systematic review and meta-analysis. Eur. Arch. Otorhinolaryngol. 279, 1675-1690 (2022).</Citation></Reference><Reference><Citation>Pereira, M., Dantas Damascena, A., Galv&#xe3;o Azevedo, L.M., de Almeida, O.T. &amp; da Mota, S.J. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 62, 1308-1316 (2022).</Citation></Reference><Reference><Citation>Pillay, J., Rahman, S., Guitard, S., Wingert, A. &amp; Hartling, L. Risk factors and preventive interventions for post Covid-19 condition: systematic review. Emerg. Microbes Infect. 11, 2762-2780 (2022).</Citation></Reference><Reference><Citation>Shams, M., Basati, G., Kalvandi, G., Abdoli, A. &amp; Tavan, H. Frequency of underlying diseases, symptoms and mortality rate of COVID-19: a systematic review and meta-analysis. Rev. Res. Med. Microbiol. 33, e189-e197 (2022).</Citation></Reference><Reference><Citation>Raeisi, T. et al. The negative impact of obesity on the occurrence and prognosis of the 2019 novel coronavirus (COVID-19) disease: a systematic review and meta-analysis. Eat. Weight Disord. 27, 893-911 (2022).</Citation></Reference><Reference><Citation>Rottler, M. et al. Clinical Frailty Scale (CFS) indicated frailty is associated with increased in-hospital and 30-day mortality in COVID-19 patients: a systematic review and meta-analysis. Ann. Intensive Care 20, 17 (2022).</Citation></Reference><Reference><Citation>Roy, S. &amp; Demmer, R.T. Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes. Transl. Res. 241, 52-69 (2022).</Citation></Reference><Reference><Citation>Subramaniam, A. et al. Frailty and mortality associations in patients with COVID-19: a systematic review and meta-analysis. Intern. Med. J. 52, 724-739 (2022).</Citation></Reference><Reference><Citation>Sunjaya, A.P., Allida, S.M., Di Tanna, G.L. &amp; Jenkins, C.R. Asthma and COVID-19 risk: a systematic review and meta-analysis. Eur. Respir. J. 59, 2101209 (2022).</Citation></Reference><Reference><Citation>Szarpak, L. et al. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19: a systematic review and meta-analysis. Cardiol. J. 29, 33-43 (2022).</Citation></Reference><Reference><Citation>Wang, Z. et al. Association of vitamin D deficiency with COVID-19 infection severity: systematic review and meta-analysis. Clin. Endocrinol. (Oxf) 96, 281-287 (2022).</Citation></Reference><Reference><Citation>Zaboli, R., Mousavi, S.M., Bahadori, M., Mehdizadeh, P., Asgharzadeh, A. &amp; Delavari, A. Influential factors on the hospitalization length of COVID-19 patients: a systematic review. Trauma Mon. 27, 82-99 (2022).</Citation></Reference><Reference><Citation>Harwood, R. et al. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: a systematic review and individual patient meta-analysis. EClinicalMedicine 44, 101287 (2022).</Citation></Reference><Reference><Citation>Widjanarko, M.W., Nindya, M., Fernandez, G. &amp; Jovito, A. Comorbidities and COVID-19 severity in pediatric patients: systematic review and meta-analysis. Paediatr. Indones. 62, 51-60 (2022).</Citation></Reference><Reference><Citation>da Silva, O., Kist, M.L., Hanzen Andrades, G.R., Drumond Costa, C.A., Crestani, F. &amp; Ramos Garcia, P.C. Weight excess association with severity in children and adolescents with COVID-19: a systematic review. Clin. Nutr. Espen. 49, 114-120 (2022).</Citation></Reference><Reference><Citation>Mongkonsritragoon, W. et al. Prevalence and risk associated with asthma in children hospitalized with SARS-CoV-2: a meta-analysis and systematic review. J. Allergy Clin. Immunol. Pract. 10, 1382-1384 (2022).e1.</Citation></Reference><Reference><Citation>Choi, J.H., Choi, S.H. &amp; Yun, K.W. Risk factors for severe COVID-19 in children: a systematic review and meta-analysis. J. Korean Med. Sci. 37, e35 (2022).</Citation></Reference><Reference><Citation>Zou, Y., Han, M., Wang, J., Zhao, J., Gan, H. &amp; Yang, Y. Predictive value of frailty in the mortality of hospitalized patients with COVID-19: a systematic review and meta-analysis. Ann. Transl. Med. 10, 166 (2022).</Citation></Reference><Reference><Citation>Szarpak, L. et al. Effect of coronary artery disease on COVID-19-prognosis and risk assessment: a systematic review and meta-analysis. Biology 11, 221 (2022).</Citation></Reference><Reference><Citation>Mude, W., Oguoma, V.M., Nyanhanda, T., Mwanri, L. &amp; Njue, C. Racial disparities in COVID-19 pandemic cases, hospitalisations, and deaths: a systematic review and meta-analysis. J. Glob. Health 11, 05015 (2021).</Citation></Reference><Reference><Citation>Mackey, K. et al. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths. A systematic review. Ann. Intern. Med. 174, 362-373 (2021).</Citation></Reference><Reference><Citation>Magesh, S. et al. Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: a systematic review and meta-analysis. JAMA Netw. Open 4, e2134147 (2021).</Citation></Reference><Reference><Citation>Tracking SARS-CoV-2 variants &lt;https://www.who.int/activities/tracking-SARS-CoV-2-variants&gt;. Accessed January 6, 2023.</Citation></Reference><Reference><Citation>Chen, S. et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet 395, 1305-1314 (2020).</Citation></Reference><Reference><Citation>Munblit, D. et al. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir. Med. 10, 715-724 (2022).</Citation></Reference><Reference><Citation>Stephenson, T. et al. Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch. Dis. Child. 107, 674-680 (2022).</Citation></Reference><Reference><Citation>Williamson, A.E., Tydeman, F., Miners, A., Pyper, K. &amp; Martineau, A.R. Short-term and long-term impacts of COVID-19 on economic vulnerability: a population-based longitudinal study (COVIDENCE UK). BMJ Open 12, e065083 (2022).</Citation></Reference><Reference><Citation>Treskova-Schwarzbach, M. et al. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 19, 212 (2021).</Citation></Reference><Reference><Citation>Wang, S.V. et al. STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies. BMJ 12, m4856 (2021).</Citation></Reference><Reference><Citation>ENCePP Home Page &lt;https://www.encepp.eu/standards_and_guidances/methodologicalGuide.shtml&gt;. Accessed January 6, 2023.</Citation></Reference><Reference><Citation>Guidelines for Good Pharmacoepidemiology Practices (GPP) - International Society for Pharmacoepidemiology &lt;https://www.pharmacoepi.org/resources/policies/guidelines-08027/&gt;. Accessed January 6, 2023.</Citation></Reference><Reference><Citation>Raynaud, M. et al. COVID-19-related medical research: a meta-research and critical appraisal. BMC Med. Res. Methodol. 21, 1 (2021).</Citation></Reference><Reference><Citation>El-Menyar, A. et al. Publications and retracted articles of COVID-19 pharmacotherapy-related research: a systematic review. Sci. Prog. 104, 368504211016936 (2021).</Citation></Reference><Reference><Citation>Capodici, A., Salussolia, A., Sanmarchi, F., Gori, D. &amp; Golinelli, D. Biased, wrong and counterfeited evidences published during the COVID-19 pandemic, a systematic review of retracted COVID-19 papers. Qual. Quant. (2022). https://doi.org/10.1007/s11135-022-01587-3.</Citation></Reference><Reference><Citation>Accorsi, E.K. et al. How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19. Eur. J. Epidemiol. 36, 179-196 (2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>